$2.79
00.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Inozyme Pharma (INZY) Forecast
NewsEarningsInozyme Pharma (INZY) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInozyme Pharma (NASDAQ:INZY) Stock Quotes, Forecast and News Summary
Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inozyme Pharma (INZY) stock?
You can purchase shares of Inozyme Pharma (NASDAQ:INZY) through any online brokerage.
Who are Inozyme Pharma (INZY) competitors?
Other companies in Inozyme Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), Galectin Therapeutics (NASDAQ:GALT), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).
What is the forecast, or price target, for Inozyme Pharma (INZY) stock?
Inozyme Pharma has a consensus price target of $14.88.
What is the current price for Inozyme Pharma (INZY)?
The stock price for Inozyme Pharma (NASDAQ: INZY) is $2.79 last updated November 20, 2024 at 4:00 PM EST.
Does Inozyme Pharma (INZY) pay a dividend?
There are no upcoming dividends for Inozyme Pharma.
When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?
Inozyme Pharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Inozyme Pharma (INZY) going to split?
There is no upcoming split for Inozyme Pharma.
What sector and industry does Inozyme Pharma (INZY) operate in?
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.